Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Other financing activities (2018 - 2024)

Crinetics Pharmaceuticals (CRNX) has 3 years of Other financing activities data on record, last reported at -$967000.0 in Q4 2024.

  • For Q4 2024, Other financing activities fell 1224.42% year-over-year to -$967000.0; the TTM value through Dec 2025 reached $3.4 million, down 13.99%, while the annual FY2024 figure was $15.0 million, 2669.32% up from the prior year.
  • Other financing activities reached -$967000.0 in Q4 2024 per CRNX's latest filing, down from $4.3 million in the prior quarter.
  • Across five years, Other financing activities topped out at $4.3 million in Q1 2024 and bottomed at -$967000.0 in Q4 2024.